These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 33013794)
1. Differential Gut Microbiota and Fecal Metabolites Related With the Clinical Subtypes of Myasthenia Gravis. Tan X; Huang Y; Chai T; Zhao X; Li Y; Wu J; Zhang H; Duan J; Liang W; Yin B; Cheng K; Yu G; Zheng P; Xie P Front Microbiol; 2020; 11():564579. PubMed ID: 33013794 [TBL] [Abstract][Full Text] [Related]
2. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients. Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837 [TBL] [Abstract][Full Text] [Related]
3. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis. Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800 [TBL] [Abstract][Full Text] [Related]
4. Study of serum exosome miRNA as a biomarker for early onset adult ouclar myastthenia gravis. Mu Y; Huang X; Yang Y; Huang Z; Chen J; Li S; Dong Y; Chen F; Zhang R; Chen J; Feng H; Zhou Q Gene; 2024 Feb; 896():148034. PubMed ID: 38013129 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis. Rao J; Li S; Wang X; Cheng Q; Ji Y; Fu W; Huang H; Shi L; Wu X Front Med (Lausanne); 2022; 9():851808. PubMed ID: 35755064 [TBL] [Abstract][Full Text] [Related]
6. Response to treatment in pediatric ocular myasthenia gravis. Xu L; Castro D; Reisch JS; Iannaccone ST Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555 [TBL] [Abstract][Full Text] [Related]
7. Different molecular expression in thymoma with ocular or generalized myasthenia gravis. Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402 [TBL] [Abstract][Full Text] [Related]
8. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic. Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334 [TBL] [Abstract][Full Text] [Related]
9. Expression of immune molecules CD25 and CXCL13 correlated with clinical severity of myasthenia gravis. Zhang M; Guo J; Li H; Zhou Y; Tian F; Gong L; Wang X; Li Z; Zhang W J Mol Neurosci; 2013 Jun; 50(2):317-23. PubMed ID: 23397576 [TBL] [Abstract][Full Text] [Related]
10. Oxidative modifications of blood serum proteins in myasthenia gravis. Adamczyk-Sowa M; Bieszczad-Bedrejczuk E; Galiniak S; Rozmiłowska I; Czyżewski D; Bartosz G; Sadowska-Bartosz I J Neuroimmunol; 2017 Apr; 305():145-153. PubMed ID: 28284335 [TBL] [Abstract][Full Text] [Related]
11. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody. Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855 [TBL] [Abstract][Full Text] [Related]
12. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up. Kupersmith MJ J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863 [TBL] [Abstract][Full Text] [Related]
13. Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study. Hendricks TM; Bhatti MT; Hodge DO; Chen JJ Am J Ophthalmol; 2019 Sep; 205():99-105. PubMed ID: 31077669 [TBL] [Abstract][Full Text] [Related]
14. Characterization of patients with ocular myasthenia gravis - A case series. Karni A; Asmail A; Drory VE; Kolb H; Kesler A eNeurologicalSci; 2016 Sep; 4():30-33. PubMed ID: 29430546 [TBL] [Abstract][Full Text] [Related]
15. Single-fiber Electromyography in the Extensor Digitorum Communis for the Predictive Prognosis of Ocular Myasthenia Gravis: A Retrospective Study of 102 Cases. Guan YZ; Cui LY; Liu MS; Niu JW Chin Med J (Engl); 2015 Oct; 128(20):2783-6. PubMed ID: 26481746 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for ocular myasthenia gravis: an observational study in Japan. Narita T; Nakane S; Nagaishi A; Minami N; Niino M; Kawaguchi N; Murai H; Kira JI; Shimizu J; Iwasa K; Yoshikawa H; Hatanaka Y; Sonoo M; Shimizu Y; Matsuo H Ther Adv Neurol Disord; 2023; 16():17562864231163819. PubMed ID: 37051222 [TBL] [Abstract][Full Text] [Related]
17. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill. Chen R; Wang J; Zhan R; Zhang L; Wang X J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318 [TBL] [Abstract][Full Text] [Related]
18. Perturbed Microbial Ecology in Myasthenia Gravis: Evidence from the Gut Microbiome and Fecal Metabolome. Zheng P; Li Y; Wu J; Zhang H; Huang Y; Tan X; Pan J; Duan J; Liang W; Yin B; Deng F; Perry SW; Wong ML; Licinio J; Wei H; Yu G; Xie P Adv Sci (Weinh); 2019 Sep; 6(18):1901441. PubMed ID: 31559142 [TBL] [Abstract][Full Text] [Related]